Total Liabilities for Novo Nordisk (NVO)
According to Novo Nordisk's latest reported financial statements, the company's latest reported total liabilities is $348.86B USD. Total liabilities sum everything the company owes at the end of each reporting period — accounts payable, accrued expenses, debt, lease obligations, and other claims — as filed on the balance sheet. Compare with total assets and net assets for solvency context.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
NVO
Currently viewingRevenueSwitch metric
Latest period
$348.86B
YoY change
+8.2%
5Y CAGR
+91.9%
Peak year (2025)
$348.86B
Latest annual
$348.86B
Total Liabilities history chart for Novo Nordisk (NVO) from 1985 to 2025
Total Liabilities history table for Novo Nordisk (NVO) from 1985 to 2025
| Fiscal year | Period ended | Reported | Total Liabilities | YoY |
|---|---|---|---|---|
| 2025 | $348.86B | +8.2% | ||
| 2024 | $322.31B | +55.0% | ||
| 2023 | $207.93B | +31.8% | ||
| 2022 | $157.77B | +27.5% | ||
| 2021 | $123.76B | +822.7% | ||
| 2020 | $13.41B | +31.3% | ||
| 2019 | $10.22B | -82.7% | ||
| 2018 | $58.93B | +12.2% | ||
| 2017 | $52.54B | +0.5% | ||
| 2016 | $52.27B | +16.6% | ||
| 2015 | $44.83B | +21.9% | ||
| 2014 | $36.77B | +32.4% | ||
| 2013 | $27.77B | +10.9% | ||
| 2012 | $25.04B | -8.1% | ||
| 2011 | $27.25B | +11.5% | ||
| 2010 | $24.44B | +28.6% | ||
| 2009 | $19.01B | +7.6% | ||
| 2008 | $17.67B | +13.5% | ||
| 2007 | $15.57B | +6.9% | ||
| 2006 | $14.57B | +1.8% | ||
| 2005 | $14.30B | +29.9% | ||
| 2004 | $11.01B | +19.7% | ||
| 2003 | $9.19B | +7.4% | ||
| 2002 | $8.56B | -2.2% | ||
| 2001 | $8.75B | -1.2% | ||
| 2000 | $8.86B | -28.7% | ||
| 1999 | $12.41B | +33.4% | ||
| 1998 | $9.30B | +23.9% | ||
| 1997 | $7.51B | +49.5% | ||
| 1996 | $5.02B | -12.3% | ||
| 1995 | $5.72B | -28.4% | ||
| 1994 | $8.00B | +9.8% | ||
| 1993 | $7.29B | +17.1% | ||
| 1992 | $6.22B | +7.8% | ||
| 1991 | $5.77B | +5.5% | ||
| 1990 | $5.47B | +1.3% | ||
| 1989 | $5.40B | +46.0% | ||
| 1988 | $3.70B | +19.3% | ||
| 1987 | $3.10B | -23.9% | ||
| 1986 | $4.08B | +66.6% | ||
| 1985 | $2.45B | — |
Total Liabilities values are taken from Novo Nordisk's reported balance sheets (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in DKK as filed.
Analysis
2025's annual total liabilities for Novo Nordisk (NVO) came in at $348.86B – grew 8.2% year-over-year.
Novo Nordisk total liabilities compound annual growth for the 2020–2025 (5 years) window is +91.9%, with the latest reading among the more recent periods of the dataset.
$348.86B stands as the all-time-high annual total liabilities, posted in 2025, against a low of $2.45B during 1985.
Novo Nordisk (NVO) sits 1st of 8 Healthcare peers we track on this metric, against a peer median of $85.07B.
Novo Nordisk Total Liabilities by Year
Novo Nordisk Total Liabilities 2025: $348.86B
Novo Nordisk total liabilities in 2025 was $348.86B, grew 8.2% from 2024. This figure represents the highest annual value in the available history.
Novo Nordisk Total Liabilities 2024: $322.31B
Novo Nordisk total liabilities in 2024 was $322.31B, surged 55.0% from 2023.
Novo Nordisk Total Liabilities 2023: $207.93B
Novo Nordisk total liabilities in 2023 was $207.93B, surged 31.8% from 2022.
Novo Nordisk Total Liabilities 2022: $157.77B
Novo Nordisk total liabilities in 2022 was $157.77B, grew 27.5% from 2021.
Novo Nordisk Total Liabilities 2021: $123.76B
Novo Nordisk total liabilities in 2021 was $123.76B.
See more financial history for Novo Nordisk (NVO).
Sector peers — Total Liabilities
Companies in the same sector as Novo Nordisk, ranked by their latest total liabilities.
| Company | Total Liabilities | Sector |
|---|---|---|
| UnitedHealth Group Incorporated (UNH) | $207.88B | Healthcare |
| AbbVie Inc. (ABBV) | $137.19B | Healthcare |
| Johnson & Johnson (JNJ) | $117.67B | Healthcare |
| Eli Lilly and Company (LLY) | $85.94B | Healthcare |
| Merck & Co., Inc. (MRK) | $84.20B | Healthcare |
| Amgen Inc. (AMGN) | $81.93B | Healthcare |
| AstraZeneca PLC (AZN) | $65.36B | Healthcare |
| Thermo Fisher Scientific Inc. (TMO) | $56.81B | Healthcare |
Frequently asked questions
What is Novo Nordisk's total liabilities?
- Latest reported total liabilities for Novo Nordisk (NVO) is $348.86B (period ending December 31, 2025).
How has Novo Nordisk total liabilities changed year-over-year?
- Novo Nordisk (NVO) total liabilities changed +8.2% year-over-year on the latest annual filing.
What is the long-term growth rate of Novo Nordisk total liabilities?
- Novo Nordisk (NVO) total liabilities compound annual growth rate is +91.9% over the most recent 5 years available.
When did Novo Nordisk total liabilities hit its highest annual value?
- Novo Nordisk total liabilities reached its highest annual value of $348.86B in 2025.
What was Novo Nordisk total liabilities in 2024?
- Novo Nordisk (NVO) total liabilities in 2024 was $322.31B.
What was Novo Nordisk total liabilities in 2025?
- Novo Nordisk (NVO) total liabilities in 2025 was $348.86B.
Metrics overview
Pick a metric for charts, filings, and peers — each row shows the latest TTM or annual value with year-over-year change.
Explore more
NVO Overview
Company profile, financial tools, and key metrics
NVO Revenue Counter
Earns 9,800 DKK every second. See per minute, hour, and day.
NVO Earnings Counter
Earns 3,248 DKK per second net profit. See per minute, hour, and day.
NVO What If Invested
What if you had invested $1,000? See historical returns from any date.
NVO How It Makes Money
Discover visual breakdown of 309.06B DKK in revenue — where it comes from and where it goes.
NVO Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
NVO Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
NVO Daily Price Character
Balanced · 47.3% historical win rate (green days). Streaks & record days.
NVO Buybacks
0.10% TTM buyback yield. Shareholder yield & SBC comparison.
NVO Stock Split History
5 splits on record. Dates, ratios, and cumulative multiple.
NVO Dividend Profile
Yield: 4.62%. Safety: 5/8. See full history.
NVO Dividend Calculator
How much dividend income would $1,000 have earned? Calculate from any date.
NVO Dividend Forecast
Project future income with DRIP, growth assumptions, and optional monthly contributions.